The expression and cell-membrane distribution of the beta 1 family of
integrins (very-late-
activation antigens, VLA) were investigated in benign and malignant human thyroid
tumors. We compared tissue samples of normal glands,
nodular goiters,
adenomas and
carcinomas. We also examined 3
thyroid-carcinoma cell lines cultured in vitro. The expression of subunits of the beta 1 family of
integrins was assessed by flow cytometry and specific
antibodies in dispersed single-cell
suspensions and by immunofluorescence on frozen tissue sections. In contrast to the heterogeneity of the expression of beta 1
integrins observed in other
tumors, thyroid neoplastic lesions showed a remarkably constant VLA profile. In all
tumors, benign as well as malignant, and in
carcinoma cell lines, all sub-units of beta 1
integrins were expressed at high levels. While sub-units alpha 1, alpha 3, alpha 5, alpha 6 and occasionally alpha 2 were also present in a cell sub-set of normal glands and
nodular goiters, expression of alpha 4 was restricted to neoplastic lesions; this
integrin can be therefore considered an
antigen associated with thyroid
tumors. It has been reported that in normal glands and in
nodular goiters, the expression of beta 1
integrins is restricted to the basal-cell membrane. Immunofluorescence on tissue sections showed instead that, in
adenomas and
carcinomas, the polarized distribution of these
integrins on the cell membrane is lost.